FDA Warning Letter — Exxon

Case 725304 — FEI 3009621552

The FDA took a Warning Letter action against Exxon on Mar 12, 2026 (Lyndhurst, NJ). The action was issued by CTP and concerns tobacco products.

Action details

Facility
Exxon
Date
Mar 12, 2026
Fiscal Year
2026
Product Type
Tobacco
Center
CTP
Location
Lyndhurst, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.